Stanford Scientists Discover Common Genetic Factor That Fends Off Alzheimer’s and Parkinson’s
Stanford Medicine researchers and international colleagues discovered that about 20% of people carry a gene variant that reduces the risk of Alzheimer’s and Parkinson’s diseases by over 10%. This variant, known as DR4, could potentially enhance the efficacy of a future vaccine against these neurodegenerative conditions. The study, involving extensive global data analysis, also suggests a link between the tau protein and both diseases, opening new avenues for targeted therapies and vaccines.
A large-scale analysis of…